Ranjeet Ajmani Invites You To Join The AABB-AATM Joint Webinar on Plasma Fractionation
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, shared on LinkedIn:
”Plasma-Derived Medicinal Products (PDMPs) are life-saving therapies used to treat a wide range of medical conditions, including immune deficiencies, bleeding disorders, and various rare diseases.
These products are derived from human plasma, which can be collected in two ways: by separating it from donated whole blood (Recovered Plasma) or through a dedicated plasma donation process (Source Plasma).
The manufacturing of PDMPs involves a highly specialized and strictly regulated process called plasma fractionation, where different plasma proteins are separated and purified for therapeutic use.
Since plasma is the primary raw material for these products, ensuring its high quality and safety is of utmost importance.”
Stay informed on all coming webinars and seminars in Hematology with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp